Moderna Being Reviewed for WHO Emergency Listing

French Junior Industry Minister Agnes Pannier-Runacher holds a box of Modern vaccine as she visits the pharmaceutical plant Recipharm on April 22, 2021 in Monts, Central France. (Getty)

GENEVA (Reuters) - Moderna's COVID-19 vaccine is being reviewed on Monday by technical experts for possible WHO emergency use listing, a World Health Organization spokesman told Reuters.

"Moderna is being reviewed at the TAG (technical advisory group) meeting today," WHO spokesman Christian Lindmeier said in reply to a query. A decision on the U.S. drugmaker's vaccine was expected in one to four days, he said.

So far COVID-19 vaccines made by Pfizer, AstraZeneca and Johnson & Johnson have already received WHO approval, which is a signal to national regulatory authorities on a product's safety and efficacy.